Hanif Esmail

Hanif Esmail i

University College London - London / United Kingdom
Others
AD Scientific Index ID: 1333044
person_outline Hanif Esmail's MOST POPULAR ARTICLES
1-) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialO Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...The Lancet 397 (10285), 1637-1645, 202114212021
2-) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trialO Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...The Lancet 397 (10289), 2049-2059, 2021636*2021
3-) The ongoing challenge of latent tuberculosisH Esmail, CE Barry 3rd, DB Young, RJ WilkinsonPhilosophical Transactions of the Royal Society B: Biological Sciences 369 …, 20143972014
4-) Prednisolone and Mycobacterium indicus pranii in Tuberculous PericarditisBM Mayosi, M Ntsekhe, J Bosch, S Pandie, H Jung, F Gumedze, J Pogue, ...New England Journal of Medicine 371 (12), 1121-1130, 20143072014
5-) Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysisO Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ...The Lancet 400 (10349), 359-368, 20222632022